Freezing cancer cells: new combo therapy shows promise for metastatic disease
NCT ID NCT04150939
First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study tests whether freezing tumors with a probe (cryoablation) can boost the effects of standard immunotherapy in people with metastatic cancer. About 15 participants will receive cryoablation on some of their tumors while continuing their usual immunotherapy. The goal is to see if this combination leads to more tumors shrinking or disappearing, helping control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.